
Agilent Technologies (A) Stock Forecast & Price Target
Agilent Technologies (A) Analyst Ratings
Bulls say
Agilent Technologies is in a strong financial position with a diversified customer base and a growing presence in the biopharmaceutical and chemical industries. Their recent product launches have shown early commercial traction and their IGNITE transformation initiatives have led to 200bps of pricing and increased productivity. The company remains exposed to risks such as macroeconomic challenges, competition, and potential M&A activity, but with a strong management team and potential for earnings growth, we rate Agilent Outperform with a $155 price target.
Bears say
Agilent Technologies is a leading life science and diagnostics company, currently facing material challenges in sustainability, acquisition selection, and diverse stakeholder expectations across different regions. With its exposure to cyclical end markets and fluctuating demand from certain regions, Agilent's stock is often used by investors to express views on the current macroeconomic cycle. Despite its strong track record, investors should carefully evaluate Agilent's ability to sustain high-single digit sales growth, and monitor any potential impacts from margin expansion and China's mixed markets.
This aggregate rating is based on analysts' research of Agilent Technologies and is not a guaranteed prediction by Public.com or investment advice.
Agilent Technologies (A) Analyst Forecast & Price Prediction
Start investing in Agilent Technologies (A)
Order type
Buy in
Order amount
Est. shares
0 shares